Skip to main content
. Author manuscript; available in PMC: 2011 Apr 25.
Published in final edited form as: Arch Neurol. 2009 Dec;66(12):1447–1455. doi: 10.1001/archneurol.2009.266

Figure 4.

Figure 4

Hypothetical temporal ordering of neuropathological processes in the course of Alzheimer disease and corresponding imaging in biomarker measures. Aβ indicates amyloid β; CSF, cerebrospinal fluid; FDG PET, fludeoxyglucose F 18 positron emission tomography; MCI, mild cognitive impairment; MRI, magnetic resonance imaging.